Related references
Note: Only part of the references are listed.EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
A Robust High Throughput Platform to Generate Functional Recombinant Monoclonal Antibodies Using Rabbit B Cells from Peripheral Blood
Stefan Seeber et al.
PLOS ONE (2014)
EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis
Alexandra N. Colebatch et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling
Xiaomeng Wang et al.
NATURE (2013)
Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis
Satoshi Serada et al.
INFLAMMATORY BOWEL DISEASES (2012)
American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
David T. Felson et al.
ARTHRITIS AND RHEUMATISM (2011)
iTRAQ-based proteomic identification of leucine-rich α-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases
Satoshi Serada et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization
Tomoyuki Igawa et al.
NATURE BIOTECHNOLOGY (2010)
Up-regulation of the expression of leucine-rich α2-glycoprotein in hepatocytes by the mediators of acute-phase response
Ryoichi Shirai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Tocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorates joint swelling in established monkey collagen-induced arthritis
Yasushi Uchiyama et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
Early effects of tocilizumab on bone and bone marrow lesions in a collagen-induced arthritis monkey model
Atsuhiko Kato et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2008)
Share Paper
